Laura Zhu

Laura Zhu is currently the Chief Business Officer and Board Member at AmMax Bio., Inc., a clinical stage biotech company specializing in oncology. With previous experience at LifeMax Laboratories, Inc. and Impax Pharmaceuticals, Laura has a background in developing therapeutics for rare diseases and neurological disorders. Laura holds an MBA from The University of Chicago Booth School of Business, a Ph.D. in Molecular Genetics from the University of Pittsburgh, and a BS in Biochemistry from Peking University.